The stock market performance of Madrigal Pharmaceuticals Inc has been very steady. Over the last year, the company’s stock hit its highest at $322.67 on 05/01/23, while the lowest price during the same time frame was $119.76, recorded on 10/27/23.
52-week price history of MDGL Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Madrigal Pharmaceuticals Inc’s current trading price is -19.58% away from its 52-week high, while its distance from the 52-week low is 116.68%. The stock’s price range for this period has remained between $119.76 and $322.67. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.83 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.48 million over the last three months.
Financial Performance and Market Capitalization
Madrigal Pharmaceuticals Inc (MDGL) has experienced a quarterly rise of 16.80% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.16B and boasts a workforce of 376 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 208.56, with a change in price of +128.66. Similarly, Madrigal Pharmaceuticals Inc recorded 458,350 in trading volume during the last 100 days, posting a change of +98.73%.
MDGL Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MDGL stands at 0.29. Similarly, the long-term debt-to-equity ratio is also 0.29.
MDGL Stock Stochastic Average
As of today, the raw stochastic average of Madrigal Pharmaceuticals Inc over the last 50 days is at 83.97%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 72.20%. Further, the company’s Stochastic %K and %D values for the last 20 days were 85.59% and 87.40%, respectively.
MDGL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 12.15%.However, over the last six months, we can see a weaker performance of 36.27%. Over the last 30 days, the price of MDGL has fallen by 26.71%. And in the last five days, it has surged by 3.37%.
